NMRA   $2.51  -2.33% Market Closed After Close 2.5392 1.16%

Neumora Therapeutics, Inc.

EMA (20): 2026-03-03 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2026-02-06 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2026-02-06 the price crossed up the moving average line and getting closer to the MA, which means that the short-term upside trend weakens.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

Trend Type flat and up
Power medium strength
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -0.49%
EMA (20) date of signal March 3, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 43.63%
EMA (50) date of signal Feb. 6, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 43.63%
EMA (100) date of signal Feb. 6, 2026, 3 a.m.
RSI Signals bearish reversal
RSI (14) Yield -4.84%
RSI (14) date of signal March 2, 2026, 3 a.m.
MACD Signals bearish reversal
MACD Yield -12.75%
MACD date of signal Feb. 27, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -0.49%
Stochastic date of signal March 3, 2026, 3 a.m.
Updated March 4, 2026, 8:43 p.m.